Cytokines such as TNF and IL-1β effectively upregulated immunogenic markers (MHC-I, ICAM-1, CD83, and PD-L1) and enhanced antigen-specific CD8+ T cell cytotoxicity against pediatric sarcoma cell lines, including RMS [146]. The gene discussed is CD274; the disease is sarcoma.